InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Basil Thomas
15 Sep 2026
Director
Sold on a plan
100,000
$13.67
$1.37M
Aoife Brennan
29 Jun 2026
President and CEO
Sold on a plan
30,902
$13.17
$406.98K
Stephen Basil Thomas
26 Feb 2026
Director
Sold on a plan
16,313
$7.01
$114.29K
Stephen Basil Thomas
25 Feb 2026
Director
Sold on a plan
33,687
$7.00
$235.96K
Stephen Basil Thomas
13 Feb 2026
Director
Sold on a plan
10,000
$5.81
$58.14K
Stephen Basil Thomas
12 Feb 2026
Director
Sold on a plan
90,000
$5.23
$470.99K
Aoife Brennan
30 Jun 2025
President and CEO
Sold on a plan
20,618
$1.22
$25.15K
Emily Pimblett
20 Jun 2025
SVP, Finance & CAO
Sold on a plan
1,242
$1.24
$1.54K
Emily Pimblett
20 Mar 2025
SVP, Finance & CAO
Sold on a plan
1,199
$1.31
$1.57K
Emily Pimblett
19 Dec 2024
Chief Accounting Officer
Sold on a plan
1,235
$2.02
$2.49K
Emily Pimblett
20 Sep 2024
Chief Accounting Officer
Sold on a plan
9
$8.06
$72.54
Emily Pimblett
20 Sep 2024
Chief Accounting Officer
Sold on a plan
1,182
$8.18
$9.67K
Show all 45 transactions →

What was left out

Form 4 filings counted 96
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,676,580
History held since 11 Aug 2021